{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:12:20Z","timestamp":1791313940137,"version":"4.3.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000737","name":"University of Exeter","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000737","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00125-019-4822-4","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T13:02:38Z","timestamp":1550149358000},"page":"567-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["Beta cells in type 1 diabetes: mass and function; sleeping or dead?"],"prefix":"10.1007","volume":"62","author":[{"given":"Richard A.","family":"Oram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmella","family":"Evans-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"issue":"11","key":"4822_CR1","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.2337\/db10-0676","volume":"59","author":"HA Keenan","year":"2010","unstructured":"Keenan HA, Sun JK, Levine J et al (2010) Residual insulin production and pancreatic ss-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 59(11):2846\u20132853. \n                    https:\/\/doi.org\/10.2337\/db10-0676","journal-title":"Diabetes"},{"issue":"1","key":"4822_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00125-013-3067-x","volume":"57","author":"RA Oram","year":"2014","unstructured":"Oram RA, Jones AG, Besser RE et al (2014) The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57(1):187\u2013191. \n                    https:\/\/doi.org\/10.1007\/s00125-013-3067-x","journal-title":"Diabetologia"},{"issue":"2","key":"4822_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2337\/dc14-0871","volume":"38","author":"RA Oram","year":"2015","unstructured":"Oram RA, McDonald TJ, Shields BM et al (2015) Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors. Diabetes Care 38(2):323\u2013328. \n                    https:\/\/doi.org\/10.2337\/dc14-0871","journal-title":"Diabetes Care"},{"issue":"3","key":"4822_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2337\/dc11-1236","volume":"35","author":"L Wang","year":"2012","unstructured":"Wang L, Lovejoy NF, Faustman DL (2012) Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay. Diabetes Care 35(3):465\u2013470. \n                    https:\/\/doi.org\/10.2337\/dc11-1236","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"4822_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2337\/diab.27.1.S262","volume":"27","author":"S Madsbad","year":"1978","unstructured":"Madsbad S, Faber OK, Binder C, McNair P, Christiansen C, Transbol I (1978) Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Diabetes 27(Suppl 1):262\u2013264. \n                    https:\/\/doi.org\/10.2337\/diab.27.1.S262","journal-title":"Diabetes"},{"issue":"3","key":"4822_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2337\/dc14-1952","volume":"38","author":"AK Davis","year":"2015","unstructured":"Davis AK, DuBose SN, Haller MJ et al (2015) Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care 38(3):476\u2013481. \n                    https:\/\/doi.org\/10.2337\/dc14-1952","journal-title":"Diabetes Care"},{"issue":"10","key":"4822_CR7","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/dme.12504","volume":"31","author":"P McGee","year":"2014","unstructured":"McGee P, Steffes M, Nowicki M et al (2014) Insulin secretion measured by stimulated C-peptide in long-established type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)\/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study. Diabet Med 31(10):1264\u20131268. \n                    https:\/\/doi.org\/10.1111\/dme.12504","journal-title":"Diabet Med"},{"issue":"10","key":"4822_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2337\/diab.14.10.619","volume":"14","author":"W Gepts","year":"1965","unstructured":"Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14(10):619\u2013633. \n                    https:\/\/doi.org\/10.2337\/diab.14.10.619","journal-title":"Diabetes"},{"issue":"2","key":"4822_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2337\/diab.8.2.83","volume":"8","author":"N Maclean","year":"1959","unstructured":"Maclean N, Ogilvie RF (1959) Observations on the pancreatic islet tissue of young diabetic subjects. Diabetes 8(2):83\u201391. \n                    https:\/\/doi.org\/10.2337\/diab.8.2.83","journal-title":"Diabetes"},{"issue":"11","key":"4822_CR10","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00125-007-0794-x","volume":"50","author":"AE Butler","year":"2007","unstructured":"Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC (2007) Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 50(11):2323\u20132331. \n                    https:\/\/doi.org\/10.1007\/s00125-007-0794-x","journal-title":"Diabetologia"},{"issue":"8","key":"4822_CR11","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1210\/jc.2016-3806","volume":"102","author":"CJ Lam","year":"2017","unstructured":"Lam CJ, Jacobson DR, Rankin MM, Cox AR, Kushner JA (2017) \u03b2 cells persist in T1D pancreata without evidence of ongoing beta-cell turnover or neogenesis. J Clin Endocrinol Metab 102(8):2647\u20132659. \n                    https:\/\/doi.org\/10.1210\/jc.2016-3806","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"4822_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/BF00275740","volume":"30","author":"M L\u00f6hr","year":"1987","unstructured":"L\u00f6hr M, Kl\u00f6ppel G (1987) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30(10):757\u2013762","journal-title":"Diabetologia"},{"issue":"11","key":"4822_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11892-018-1084-3","volume":"18","author":"T Rodriguez-Calvo","year":"2018","unstructured":"Rodriguez-Calvo T, Richardson SJ, Pugliese A (2018) Pancreas pathology during the natural history of type 1 diabetes. Curr Diab Rep 18(11):124. \n                    https:\/\/doi.org\/10.1007\/s11892-018-1084-3","journal-title":"Curr Diab Rep"},{"issue":"2","key":"4822_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2337\/diab.21.2.114","volume":"21","author":"DJ Evans","year":"1972","unstructured":"Evans DJ (1972) Generalized islet hypertrophy and beta-cell hyperplasia in a case of long-term juvenile diabetes. Diabetes 21(2):114\u2013116. \n                    https:\/\/doi.org\/10.2337\/diab.21.2.114","journal-title":"Diabetes"},{"issue":"21","key":"4822_CR15","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","volume":"314","author":"GS Eisenbarth","year":"1986","unstructured":"Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314(21):1360\u20131368. \n                    https:\/\/doi.org\/10.1056\/NEJM198605223142106","journal-title":"N Engl J Med"},{"key":"4822_CR16","first-page":"111","volume":"23","author":"GS Eisenbarth","year":"1984","unstructured":"Eisenbarth GS (1984) Autoimmune beta cell insufficiency\u2014diabetes mellitus type 1. Triangle 23:111\u2013124","journal-title":"Triangle"},{"issue":"1","key":"4822_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00125-013-3104-9","volume":"57","author":"DL Faustman","year":"2014","unstructured":"Faustman DL (2014) Why were we wrong for so long? The pancreas of type 1 diabetic patients commonly functions for decades. Diabetologia 57(1):1\u20133. \n                    https:\/\/doi.org\/10.1007\/s00125-013-3104-9","journal-title":"Diabetologia"},{"issue":"7","key":"4822_CR18","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1007\/s00125-012-2556-7","volume":"55","author":"C Dirksen","year":"2012","unstructured":"Dirksen C, Jorgensen NB, Bojsen-Moller KN et al (2012) Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 55(7):1890\u20131901. \n                    https:\/\/doi.org\/10.1007\/s00125-012-2556-7","journal-title":"Diabetologia"},{"issue":"7","key":"4822_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nbt1115","volume":"23","author":"S Bonner-Weir","year":"2005","unstructured":"Bonner-Weir S, Weir GC (2005) New sources of pancreatic \u03b2-cells. Nat Biotechnol 23(7):857\u2013861. \n                    https:\/\/doi.org\/10.1038\/nbt1115","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4822_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrendo.2014.2","volume":"10","author":"BO Roep","year":"2014","unstructured":"Roep BO, Tree TIM (2014) Immune modulation in humans: implications for type 1 diabetes mellitus. Nat Rev Endocrinol 10(4):229\u2013242. \n                    https:\/\/doi.org\/10.1038\/nrendo.2014.2","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"4822_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pedi.12097","volume":"15","author":"A Pugliese","year":"2014","unstructured":"Pugliese A, Yang M, Kusmarteva I et al (2014) The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings. Pediatr Diabetes 15(1):1\u20139. \n                    https:\/\/doi.org\/10.1111\/pedi.12097","journal-title":"Pediatr Diabetes"},{"issue":"Suppl 1","key":"4822_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2337\/diab.27.1.S251","volume":"27","author":"W Gepts","year":"1978","unstructured":"Gepts W, De Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1):251\u2013261. \n                    https:\/\/doi.org\/10.2337\/diab.27.1.S251","journal-title":"Diabetes"},{"issue":"11","key":"4822_CR23","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00125-005-1949-2","volume":"48","author":"JJ Meier","year":"2005","unstructured":"Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48(11):2221\u20132228. \n                    https:\/\/doi.org\/10.1007\/s00125-005-1949-2","journal-title":"Diabetologia"},{"issue":"6","key":"4822_CR24","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.2337\/db07-1369","volume":"57","author":"JJ Meier","year":"2008","unstructured":"Meier JJ, Butler AE, Saisho Y et al (2008) Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 57(6):1584\u20131594. \n                    https:\/\/doi.org\/10.2337\/db07-1369","journal-title":"Diabetes"},{"issue":"3","key":"4822_CR25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/db15-0779","volume":"65","author":"M Campbell-Thompson","year":"2016","unstructured":"Campbell-Thompson M, Fu A, Kaddis JS et al (2016) Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes. Diabetes 65(3):719\u2013731. \n                    https:\/\/doi.org\/10.2337\/db15-0779","journal-title":"Diabetes"},{"issue":"Suppl 4","key":"4822_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1463-1326.2008.00969.x","volume":"10","author":"J Rahier","year":"2008","unstructured":"Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC (2008) Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10(Suppl 4):32\u201342. \n                    https:\/\/doi.org\/10.1111\/j.1463-1326.2008.00969.x","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"4822_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2337\/dc12-0421","volume":"36","author":"Y Saisho","year":"2013","unstructured":"Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC (2013) \u03b2-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care 36(1):111\u2013117. \n                    https:\/\/doi.org\/10.2337\/dc12-0421","journal-title":"Diabetes Care"},{"issue":"5","key":"4822_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/pedi.12286","volume":"16","author":"M Campbell-Thompson","year":"2015","unstructured":"Campbell-Thompson M (2015) Organ donor specimens: what can they tell us about type 1 diabetes? Pediatr Diabetes 16(5):320\u2013330. \n                    https:\/\/doi.org\/10.1111\/pedi.12286","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"4822_CR29","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.2337\/db15-1615","volume":"65","author":"P Leete","year":"2016","unstructured":"Leete P, Willcox A, Krogvold L et al (2016) Differential insulitic profiles determine the extent of beta-cell destruction and the age at onset of type 1 diabetes. Diabetes 65(5):1362\u20131369. \n                    https:\/\/doi.org\/10.2337\/db15-1615","journal-title":"Diabetes"},{"issue":"8","key":"4822_CR30","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.2337\/db11-1538","volume":"61","author":"CJ Greenbaum","year":"2012","unstructured":"Greenbaum CJ, Beam CA, Boulware D et al (2012) Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes 61(8):2066\u20132073. \n                    https:\/\/doi.org\/10.2337\/db11-1538","journal-title":"Diabetes"},{"issue":"7","key":"4822_CR31","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.2337\/dc18-0465","volume":"41","author":"BM Shields","year":"2018","unstructured":"Shields BM, McDonald TJ, Oram R et al (2018) C-Peptide decline in type 1 diabetes has two phases: an initial exponential fall and a subsequent stable phase. Diabetes Care 41(7):1486\u20131492. \n                    https:\/\/doi.org\/10.2337\/dc18-0465","journal-title":"Diabetes Care"},{"issue":"10","key":"4822_CR32","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.2337\/dc16-0360","volume":"39","author":"W Hao","year":"2016","unstructured":"Hao W, Gitelman S, DiMeglio LA, Boulware D, Greenbaum CJ (2016) Fall in C-Peptide during first 4 years from diagnosis of type 1 diabetes: variable relation to age, HbA1c, and insulin dose. Diabetes Care 39(10):1664\u20131670. \n                    https:\/\/doi.org\/10.2337\/dc16-0360","journal-title":"Diabetes Care"},{"issue":"12","key":"4822_CR33","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1007\/s00125-012-2719-6","volume":"55","author":"D Dabelea","year":"2012","unstructured":"Dabelea D, Mayer-Davis EJ, Andrews JS et al (2012) Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 55(12):3359\u20133368. \n                    https:\/\/doi.org\/10.1007\/s00125-012-2719-6","journal-title":"Diabetologia"},{"issue":"3","key":"4822_CR34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/dom.12216","volume":"16","author":"A Barker","year":"2014","unstructured":"Barker A, Lauria A, Schloot N et al (2014) Age-dependent decline of \u03b2-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study. Diabetes Obes Metab 16(3):262\u2013267. \n                    https:\/\/doi.org\/10.1111\/dom.12216","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"4822_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/diabetes.53.1.250","volume":"53","author":"JP Palmer","year":"2004","unstructured":"Palmer JP, Fleming GA, Greenbaum CJ et al (2004) C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 53(1):250\u2013264. \n                    https:\/\/doi.org\/10.2337\/diabetes.53.1.250","journal-title":"Diabetes"},{"issue":"12","key":"4822_CR36","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1007\/s00125-016-4087-0","volume":"59","author":"GM Williams","year":"2016","unstructured":"Williams GM, Long AE, Wilson IV et al (2016) Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes. Diabetologia 59(12):2722\u20132726. \n                    https:\/\/doi.org\/10.1007\/s00125-016-4087-0","journal-title":"Diabetologia"},{"issue":"1","key":"4822_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/dom.12544","volume":"18","author":"D Laurent","year":"2016","unstructured":"Laurent D, Vinet L, Lamprianou S et al (2016) Pancreatic beta-cell imaging in humans: fiction or option? Diabetes Obes Metab 18(1):6\u201315. \n                    https:\/\/doi.org\/10.1111\/dom.12544","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"4822_CR38","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.2337\/dc07-2451","volume":"31","author":"CJ Greenbaum","year":"2008","unstructured":"Greenbaum CJ, Mandrup-Poulsen T, McGee PF et al (2008) Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 31(10):1966\u20131971. \n                    https:\/\/doi.org\/10.2337\/dc07-2451","journal-title":"Diabetes Care"},{"issue":"7","key":"4822_CR39","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/dme.12159","volume":"30","author":"AG Jones","year":"2013","unstructured":"Jones AG, Hattersley AT (2013) The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 30(7):803\u2013817. \n                    https:\/\/doi.org\/10.1111\/dme.12159","journal-title":"Diabet Med"},{"issue":"4","key":"4822_CR40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1210\/jcem-67-4-785","volume":"67","author":"DK McCulloch","year":"1988","unstructured":"McCulloch DK, Raghu PK, Johnston C et al (1988) Defects in beta-cell function and insulin sensitivity in normoglycemic streptozocin-treated baboons: a model of preclinical insulin-dependent diabetes. J Clin Endocrinol Metab 67(4):785\u2013792. \n                    https:\/\/doi.org\/10.1210\/jcem-67-4-785","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"4822_CR41","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2337\/diab.40.6.673","volume":"40","author":"DK McCulloch","year":"1991","unstructured":"McCulloch DK, Koerker DJ, Kahn SE, Bonner-Weir S, Palmer JP (1991) Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboons. Diabetes 40(6):673\u2013679. \n                    https:\/\/doi.org\/10.2337\/diab.40.6.673","journal-title":"Diabetes"},{"issue":"12","key":"4822_CR42","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1210\/jc.2017-01713","volume":"102","author":"W Hao","year":"2017","unstructured":"Hao W, Wookwyk A, Beam C, Bahnson HT, Palmer JP, Greenbaum CJ (2017) Assessment of \u03b2 cell mass and function by airmax and intravenous glucose in high-risk subjects for type 1 diabetes. J Clin Endocrinol Metab 102(12):4428\u20134434. \n                    https:\/\/doi.org\/10.1210\/jc.2017-01713","journal-title":"J Clin Endocrinol Metab"},{"issue":"25","key":"4822_CR43","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1056\/NEJMoa043980","volume":"352","author":"B Keymeulen","year":"2005","unstructured":"Keymeulen B, Vandemeulebroucke E, Ziegler AG et al (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352(25):2598\u20132608. \n                    https:\/\/doi.org\/10.1056\/NEJMoa043980","journal-title":"N Engl J Med"},{"issue":"35","key":"4822_CR44","doi-asserted-by":"publisher","first-page":"13163","DOI":"10.1073\/pnas.0801059105","volume":"105","author":"H Ellingsgaard","year":"2008","unstructured":"Ellingsgaard H, Ehses JA, Hammar EB et al (2008) Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proc Natl Acad Sci U S A 105(35):13163\u201313168. \n                    https:\/\/doi.org\/10.1073\/pnas.0801059105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4822_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.20111187","volume":"209","author":"KT Coppieters","year":"2012","unstructured":"Coppieters KT, Dotta F, Amirian N et al (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209(1):51\u201360. \n                    https:\/\/doi.org\/10.1084\/jem.20111187","journal-title":"J Exp Med"},{"issue":"4","key":"4822_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrendo.2015.9","volume":"11","author":"P Wang","year":"2015","unstructured":"Wang P, Fiaschi-Taesch NM, Vasavada RC, Scott DK, Garcia-Ocana A, Stewart AF (2015) Diabetes mellitus\u2013advances and challenges in human beta-cell proliferation. Nat Rev Endocrinol 11(4):201\u2013212. \n                    https:\/\/doi.org\/10.1038\/nrendo.2015.9","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"4822_CR47","doi-asserted-by":"publisher","first-page":"e1024405","DOI":"10.1080\/19382014.2015.1024405","volume":"7","author":"J Dolensek","year":"2015","unstructured":"Dolensek J, Rupnik MS, Stozer A (2015) Structural similarities and differences between the human and the mouse pancreas. Islets 7(1):e1024405. \n                    https:\/\/doi.org\/10.1080\/19382014.2015.1024405","journal-title":"Islets"},{"issue":"9","key":"4822_CR48","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1210\/jc.2012-1206","volume":"97","author":"BE Gregg","year":"2012","unstructured":"Gregg BE, Moore PC, Demozay D et al (2012) Formation of a human beta-cell population within pancreatic islets is set early in life. J Clin Endocrinol Metab 97(9):3197\u20133206. \n                    https:\/\/doi.org\/10.1210\/jc.2012-1206","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"4822_CR49","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1007\/s00125-006-0308-2","volume":"49","author":"JJ Meier","year":"2006","unstructured":"Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49(8):1838\u20131844. \n                    https:\/\/doi.org\/10.1007\/s00125-006-0308-2","journal-title":"Diabetologia"},{"issue":"1","key":"4822_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1210\/jc.2016-3001","volume":"102","author":"AS Moin","year":"2017","unstructured":"Moin AS, Butler PC, Butler AE (2017) Increased proliferation of the pancreatic duct gland compartment in type 1 diabetes. J Clin Endocrinol Metab 102(1):200\u2013209. \n                    https:\/\/doi.org\/10.1210\/jc.2016-3001","journal-title":"J Clin Endocrinol Metab"},{"issue":"47","key":"4822_CR51","doi-asserted-by":"publisher","first-page":"19018","DOI":"10.1073\/pnas.1111008108","volume":"108","author":"EM Akirav","year":"2011","unstructured":"Akirav EM, Lebastchi J, Galvan EM et al (2011) Detection of beta cell death in diabetes using differentially methylated circulating DNA. Proc Natl Acad Sci U S A 108(47):19018\u201319023. \n                    https:\/\/doi.org\/10.1073\/pnas.1111008108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"4822_CR52","doi-asserted-by":"publisher","first-page":"E1826","DOI":"10.1073\/pnas.1519286113","volume":"113","author":"R Lehmann-Werman","year":"2016","unstructured":"Lehmann-Werman R, Neiman D, Zemmour H et al (2016) Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc Natl Acad Sci U S A 113(13):E1826\u2013E1834. \n                    https:\/\/doi.org\/10.1073\/pnas.1519286113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"4822_CR53","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.2337\/db15-0430","volume":"64","author":"MM Fisher","year":"2015","unstructured":"Fisher MM, Watkins RA, Blum J et al (2015) Elevations in circulating methylated and unmethylated preproinsulin DNA in new-onset type 1 diabetes. Diabetes 64(11):3867\u20133872. \n                    https:\/\/doi.org\/10.2337\/db15-0430","journal-title":"Diabetes"},{"issue":"1","key":"4822_CR54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/dom.13489","volume":"21","author":"A Neyman","year":"2018","unstructured":"Neyman A, Nelson J, Tersey SA, Mirmira RG, Evans-Molina C, Sims EK (2018) Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes. Diabetes Obes Metab 21(1):95\u2013102. \n                    https:\/\/doi.org\/10.1111\/dom.13489","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"4822_CR55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cmet.2017.01.005","volume":"25","author":"J Rui","year":"2017","unstructured":"Rui J, Deng S, Arazi A, Perdigoto AL, Liu Z, Herold KC (2017) \u03b2 cells that resist immunological attack develop during progression of autoimmune diabetes in NOD mice. Cell Metab 25(3):727\u2013738. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2017.01.005","journal-title":"Cell Metab"},{"key":"4822_CR56","doi-asserted-by":"publisher","unstructured":"Sims E, Bahnson H, Nyalwidhe J et al (2018) Proinsulin secretion is a persistent feature of type 1 diabetes. Diabetes Care:dc172625. \n                    https:\/\/doi.org\/10.2337\/dc17-2625","DOI":"10.2337\/dc17-2625"},{"issue":"3","key":"4822_CR57","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.cmet.2017.08.013","volume":"26","author":"C Wasserfall","year":"2017","unstructured":"Wasserfall C, Nick HS, Campbell-Thompson M et al (2017) Persistence of pancreatic insulin mRNA expression and proinsulin protein in type 1 diabetes pancreata. Cell Metab 26(3):568\u2013575. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2017.08.013","journal-title":"Cell Metab"},{"issue":"5","key":"4822_CR58","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.2337\/db16-1343","volume":"66","author":"T Rodriguez-Calvo","year":"2017","unstructured":"Rodriguez-Calvo T, Zapardiel-Gonzalo J, Amirian N et al (2017) Increase in pancreatic proinsulin and preservation of \u03b2-cell mass in autoantibody-positive donors prior to type 1 diabetes onset. Diabetes 66(5):1334\u20131345. \n                    https:\/\/doi.org\/10.2337\/db16-1343","journal-title":"Diabetes"},{"issue":"1","key":"4822_CR59","doi-asserted-by":"publisher","first-page":"11756","DOI":"10.1038\/ncomms11756","volume":"7","author":"C Dorrell","year":"2016","unstructured":"Dorrell C, Schug J, Canaday PS et al (2016) Human islets contain four distinct subtypes of beta cells. Nat Commun 7(1):11756. \n                    https:\/\/doi.org\/10.1038\/ncomms11756","journal-title":"Nat Commun"},{"issue":"3","key":"4822_CR60","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.cmet.2016.06.020","volume":"24","author":"NR Johnston","year":"2016","unstructured":"Johnston NR, Mitchell RK, Haythorne E et al (2016) Beta cell hubs dictate pancreatic islet responses to glucose. Cell Metab 24(3):389\u2013401. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2016.06.020","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"4822_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/dom.13019","volume":"19","author":"D Avrahami","year":"2017","unstructured":"Avrahami D, Wang YJ, Klochendler A, Dor Y, Glaser B, Kaestner KH (2017) \u03b2-Cells are not uniform after all-Novel insights into molecular heterogeneity of insulin-secreting cells. Diabetes Obes Metab 19(Suppl 1):147\u2013152. \n                    https:\/\/doi.org\/10.1111\/dom.13019","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"4822_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00281-010-0208-x","volume":"33","author":"PA Rowe","year":"2011","unstructured":"Rowe PA, Campbell-Thompson ML, Schatz DA, Atkinson MA (2011) The pancreas in human type 1 diabetes. Semin Immunopathol 33(1):29\u201343. \n                    https:\/\/doi.org\/10.1007\/s00281-010-0208-x","journal-title":"Semin Immunopathol"},{"issue":"3","key":"4822_CR63","doi-asserted-by":"publisher","first-page":"e1002552","DOI":"10.1371\/journal.pgen.1002552","volume":"8","author":"DL Eizirik","year":"2012","unstructured":"Eizirik DL, Sammeth M, Bouckenooghe T et al (2012) The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 8(3):e1002552. \n                    https:\/\/doi.org\/10.1371\/journal.pgen.1002552","journal-title":"PLoS Genet"},{"issue":"4","key":"4822_CR64","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00125-016-4201-3","volume":"60","author":"L Marroqui","year":"2017","unstructured":"Marroqui L, Dos Santos RS, Op de Beeck A et al (2017) Interferon-alpha mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes. Diabetologia 60(4):656\u2013667. \n                    https:\/\/doi.org\/10.1007\/s00125-016-4201-3","journal-title":"Diabetologia"},{"issue":"9","key":"4822_CR65","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00125-012-2604-3","volume":"55","author":"I Marhfour","year":"2012","unstructured":"Marhfour I, Lopez XM, Lefkaditis D et al (2012) Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia 55(9):2417\u20132420. \n                    https:\/\/doi.org\/10.1007\/s00125-012-2604-3","journal-title":"Diabetologia"},{"issue":"4","key":"4822_CR66","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm.4289","volume":"23","author":"MJ Kracht","year":"2017","unstructured":"Kracht MJ, van Lummel M, Nikolic T et al (2017) Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes. Nat Med 23(4):501\u2013507. \n                    https:\/\/doi.org\/10.1038\/nm.4289","journal-title":"Nat Med"},{"key":"4822_CR67","doi-asserted-by":"publisher","unstructured":"Gonzalez-Duque S, Azoury ME, Colli ML et al (2018) Conventional and neo-antigenic peptides presented by \u03b2 cells are targeted by circulating naive CD8+ T cells in type 1 diabetic and healthy donors. Cell Metab 28(6):946\u2013960. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2018.07.007","DOI":"10.1016\/j.cmet.2018.07.007"},{"issue":"3","key":"4822_CR68","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1210\/er.2007-0026","volume":"29","author":"A Balasubramanyam","year":"2008","unstructured":"Balasubramanyam A, Nalini R, Hampe CS, Maldonado M (2008) Syndromes of ketosis-prone diabetes mellitus. Endocr Rev 29(3):292\u2013302. \n                    https:\/\/doi.org\/10.1210\/er.2007-0026","journal-title":"Endocr Rev"},{"issue":"11","key":"4822_CR69","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1210\/jc.2003-030180","volume":"88","author":"M Maldonado","year":"2003","unstructured":"Maldonado M, Hampe CS, Gaur LK et al (2003) Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 88(11):5090\u20135098. \n                    https:\/\/doi.org\/10.1210\/jc.2003-030180","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"4822_CR70","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.2337\/db07-1817","volume":"57","author":"E Akirav","year":"2008","unstructured":"Akirav E, Kushner JA, Herold KC (2008) Beta-cell mass and type 1 diabetes: going, going, gone? Diabetes 57(11):2883\u20132888. \n                    https:\/\/doi.org\/10.2337\/db07-1817","journal-title":"Diabetes"},{"issue":"8","key":"4822_CR71","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/dc08-1987","volume":"32","author":"HB Mortensen","year":"2009","unstructured":"Mortensen HB, Hougaard P, Swift P et al (2009) New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care 32(8):1384\u20131390. \n                    https:\/\/doi.org\/10.2337\/dc08-1987","journal-title":"Diabetes Care"},{"issue":"2","key":"4822_CR72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1046\/j.1365-2796.1999.00426.x","volume":"245","author":"A Scholin","year":"1999","unstructured":"Scholin A, Berne C, Schvarcz E, Karlsson FA, Bjork E (1999) Factors predicting clinical remission in adult patients with type 1 diabetes. J Intern Med 245(2):155\u2013162. \n                    https:\/\/doi.org\/10.1046\/j.1365-2796.1999.00426.x","journal-title":"J Intern Med"},{"key":"4822_CR73","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837\u2013853","journal-title":"Lancet"},{"issue":"7","key":"4822_CR74","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.2337\/db14-1911","volume":"64","author":"L Krogvold","year":"2015","unstructured":"Krogvold L, Skog O, Sundstrom G et al (2015) Function of isolated pancreatic islets from patients at onset of type 1 diabetes: insulin secretion can be restored after some days in a nondiabetogenic environment in vitro: results from the DiViD study. Diabetes 64(7):2506\u20132512. \n                    https:\/\/doi.org\/10.2337\/db14-1911","journal-title":"Diabetes"},{"issue":"12","key":"4822_CR75","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.2337\/dc13-1074","volume":"36","author":"B Buckingham","year":"2013","unstructured":"Buckingham B, Beck RW, Ruedy KJ et al (2013) Effectiveness of early intensive therapy on \u03b2-cell preservation in type 1 diabetes. Diabetes Care 36(12):4030\u20134035. \n                    https:\/\/doi.org\/10.2337\/dc13-1074","journal-title":"Diabetes Care"},{"issue":"10","key":"4822_CR76","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00125-010-1809-6","volume":"53","author":"AE Butler","year":"2010","unstructured":"Butler AE, Cao-Minh L, Galasso R et al (2010) Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 53(10):2167\u20132176. \n                    https:\/\/doi.org\/10.1007\/s00125-010-1809-6","journal-title":"Diabetologia"},{"issue":"10","key":"4822_CR77","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1111\/j.1464-5491.2012.03747.x","volume":"29","author":"HR Murphy","year":"2012","unstructured":"Murphy HR, Elleri D, Allen JM, Simmons D, Nodale M, Hovorka R (2012) Plasma C-peptide concentration in women with type 1 diabetes during early and late pregnancy. Diabet Med 29(10):e361\u2013e364. \n                    https:\/\/doi.org\/10.1111\/j.1464-5491.2012.03747.x","journal-title":"Diabet Med"},{"issue":"6","key":"4822_CR78","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2337\/dc08-1832","volume":"32","author":"LR Nielsen","year":"2009","unstructured":"Nielsen LR, Rehfeld JF, Pedersen-Bjergaard U, Damm P, Mathiesen ER (2009) Pregnancy-induced rise in serum C-peptide concentrations in women with type 1 diabetes. Diabetes Care 32(6):1052\u20131057. \n                    https:\/\/doi.org\/10.2337\/dc08-1832","journal-title":"Diabetes Care"},{"issue":"3","key":"4822_CR79","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1573399811666150331160846","volume":"11","author":"N Montero","year":"2015","unstructured":"Montero N, Pascual J (2015) Immunosuppression and post-transplant hyperglycemia. Curr Diabetes Rev 11(3):144\u2013154. \n                    https:\/\/doi.org\/10.2174\/1573399811666150331160846","journal-title":"Curr Diabetes Rev"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4822-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-019-4822-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4822-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T19:21:29Z","timestamp":1581621689000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-019-4822-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4822"],"URL":"https:\/\/doi.org\/10.1007\/s00125-019-4822-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"30 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}